Cidara Therapeutics, Inc. (NASDAQ:CDTX) Files An 8-K Other Events
Item 8.01 Other Events.
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Files An 8-K Other Events
Cidara Therapeutics, Inc. will present at the 2019 Wedbush PacGrow Healthcare Conference on August 14, 2019>at 10:20 a.m. EDT (7:20 a.m. PDT) in New York City. The slide presentation to be presented at this conference is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Cidara Therapeutics, Inc. Exhibit
EX-99.1 2 presentation20190813.htm SLIDE PRESENTATION,…
To view the full exhibit click
EX-99.1 2 presentation20190813.htm SLIDE PRESENTATION,…
To view the full exhibit click
here
About Cidara Therapeutics, Inc. (NASDAQ:CDTX)
Cidara Therapeutics, Inc., formerly K2 Therapeutics, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery, development and commercialization of anti-infectives. It is developing a pipeline of product and development candidates with a focus on serious fungal infections. Its product portfolio consists of over two formulations of its echinocandin, CD101. CD101 IV is a long-acting therapy for the treatment and prevention of serious, invasive fungal infections. CD101 topical, its second product candidate, is being developed for the treatment of vulvovaginal candidiasis (VVC) and recurrent VVC (RVVC), a prevalent mucosal infection. Its immunotherapy technology platform, Cloudbreak, is used to create compounds designed to direct a patient’s immune cells to attack and eliminate pathogens that cause infectious disease.